| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.3M | +5.2% | +42.8% |
| Cost of Revenue | $29.3M | +6.9% | +36.6% |
| Gross Profit | $54.0M | +4.4% | +46.3% |
| R&D Expense | $18.2M | +3.1% | +9.3% |
| SG&A Expense | $59.0M | +4.8% | +38.2% |
| Operating Income | -$23.2M | -4.5% | -3.4% |
| Net Income | -$21.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $294.3M | -2.8% | +49.6% |
| Accounts Receivable | $84.5M | +4.6% | +22.4% |
| Inventory | $66.7M | -0.5% | +31.2% |
| Current Assets | $454.8M | -0.7% | +40.8% |
| Total Assets | $511.5M | -0.3% | +36.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$38.7M | — | — |
| Capital Expenditures | $7.5M | — | — |
| Investing Cash Flow | -$7.5M | — | — |
| Financing Cash Flow | $6.8M | — | — |
| Free Cash Flow | -$46.2M | — | — |
| -9.4% |
| -2.1% |
| EPS (Basic) | -$0.38 | -8.6% | +5.0% |
| EPS (Diluted) | -$0.38 | -8.6% | +5.0% |
| $53.9M |
| +8.4% |
| +0.5% |
| Long-term Debt | $51.6M | +0.1% | +0.2% |
| Total Liabilities | $131.3M | +3.1% | -1.2% |
| Stockholders' Equity | $380.3M | -1.4% | +57.6% |